SARA KIELHORN: Open Payments
NPI 1134558034 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 79 payments from 12 companies in 2025. Trend: 2023 $1,697 · 2024 $1,510 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $289 |
| Aimmune Therapeutics, Inc. | 19 | $233 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $222 |
| Janssen Biotech, Inc. | 10 | $155 |
| QOL Medical, LLC | 2 | $64 |
| Celltrion USA Inc. | 3 | $47 |
| Ardelyx, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| PFIZER INC. | 2 | $32 |
| Organon LLC | 1 | $17 |
Products named: ZENPEP, XIFAXAN, MAVYRET, TREMFYA, LINZESS, Sucraid, VEGZELMA, IBSRELA.
Industry payments across TX — which companies pay providers there.
